Regenerative Medicine

Category

Physician in Savannah, Georgia, Embraces Investigational Regenerative Acellular-based Therapy to Treat COVID-19 Long Haulers on FDA Expanded Access Protocol

With over 12 million COVID-19 cases and growing, some physicians become ever more open and innovative in their quest to treat their patients. Take Dr. Allen Meglin, practicing in Savannah, Georgia, who now has internalized the need to deal with the frightening next...

Novartis Pays $50m Upfront Cash for License and Stock in Mesoblast to Access Mesenchymal Stromal Cells Regenerative Therapy Platform

Novartis recently inked an exclusive worldwide license and collaboration agreement with regenerative therapy venture Mesoblast to develop, commercialize and manufacture remestemcel-L for the treatment of acute respiratory distress syndrome (ARDS), including that...

Hackensack University Medical Center Offers Clinical Trial to Investigate Nerve Recovery Post Robotic Prostatectomy for Prostate Cancer

Hackensack Meridian Hackensack University Medical Center’s Department of Urology is among the first in the nation to embrace bioregenerative medicine as a new way to promote nerve regeneration and a faster return to normal erectile and urinary function after...

Landmark Hospitals Compassionate Use Study for Critical COVID-19 Patients Evidences Potential for Allogenic Biologic Product

Landmark Hospital manages six long-term acute care hospitals across the Southeast United States and recently announced its decision to offer an investigational allogenic biologic product derived from amniotic fluid to patients with advanced COVID-19 conditions under...

Mesoblast Raises $138m from Investors to Scale Making of Remestemcel-L for COVID-19 ARDS Patients

Australia-based Mesoblast (ASX: MSB; Nasdaq: MESO) just raised $138 million from investors. The company positions itself as a leader in cellular medicines for inflammatory diseases, placed 43 million shares to existing new institutional investors at a price of A$3.20...

Tel Aviv Sourasky Medical Center Leases State-of-the-Art Cleanrooms to Biotechnology for Advanced Production

Tel Aviv Sourasky Medical Center has entered into an agreement to expand on an existing collaboration and lease three state-of-the-art cleanrooms with an Israeli adult stem cell therapy manufacturer, enabling the company to significantly increase their capacity to...

The FDA Approving Experimental Stem Cell Therapies Targeting Patients with Severe COVID-19 Cases

Novel medical innovations are being pursued by biotech companies and clinical investigators to halt COVID-19 causalities as there is, presently, no approved treatment for the novel coronavirus—especially in severe, escalated conditions where mortality is more...

Regenerative Research in China Targeting COVID-19 Gains Momentum—Evidence of Some Success and an American Venture

Worldwide researchers and clinical investigators develop vaccines, therapeutic treatments and diagnostic tests to take on COVID-19 and in China in addition to these activities some physicians are declaring some initial success utilizing stem cell therapy. Could this...

CSL Behring & University City Science Center Accelerate Research for New Biotherapies with Grant Awards

University of Pittsburgh and University of Delaware researchers received funding for research covering innovative therapies targeting pulmonary fibrosis (FB) to Gene delivery to or editing Hematopoietic (blood) Stem and Progenitor Cells (HSPCs). Two clinical...

Pin It on Pinterest